article thumbnail

Pharmacy Benefit Manager Reform: What’s on the Horizon?

McDermott Will & Emery Employee Benefits

Congress and other policymakers continue to seek opportunities to lower costs for patients and the federal government. Pharmacy benefit managers (PBMs) are a key stakeholder in the drug supply chain, functioning as intermediaries between insurance providers and pharmaceutical manufacturers. appeared first on EMPLOYEE BENEFITS BLOG.

article thumbnail

New Insulin Price Cap Could End Up Saving Payers Money in the Long Run

HR Digest

Reducing out-of-pocket cost-sharing for insulin does mean payers and insurers may be covering a greater share of the costs. However, some of those costs may be offset by increased medication adherence and reduced hospitalization rates, which would end up saving payers money in the long run.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Injured PA Workers’ Comp Attorney Should Have Been Reimbursed for Cost of Cannabinoid (CBD) Oil Prescription

The Workcomp Writer

Employer Refuses Reimbursement Request When the claimant provided his law firm employer with the CBD oil prescription and receipts for its purchase, the law firm refused to reimburse the claimant’s out-of-pocket CBD oil expenses on the basis that CBD oil was not a pharmaceutical drug.

Medical 52
article thumbnail

8 Ways Employers and Employees Can Save On Prescription Medications

Griffin Benefits

And while consumers seem to have a love/hate relationship with HDHPs, many of those who take the time to fully calculate the total out-of-pocket cost of medical coverage and care realize that HDHPs, even with higher deductibles, can often save them money. Pharmaceutical Company & State Drug Assistance Programs.

Medical 52
article thumbnail

New Transparency Requirements for Health Plans

AssuredPartners

These rules do not apply to pharmaceutical carve-out plans, as they are aimed at transparency in pricing regarding treatment at health care facilities. No Surprises Act provisions Effective January 1, 2022, the No Surprises Act requires the following of self-funded and fully insured health plans as pertains to transparency.

article thumbnail

3 Ways to Strengthen Cost Management for Pharmaceutical Benefits

Griffin Benefits

Because of its increased percentage of total drug spending, specialty drug costs are proving a major headache for plan sponsors. They need to find ways to control spending on these treatments, lest the cost of the drug benefit become prohibitive. Here are three ways to manage the cost of pharmaceutical benefits.

article thumbnail

Insulin Makers Cap Prices for Insured Individuals

InterWest Insurance Services

The changes mean some or many of your employees will see significant reductions in their pharmaceutical outlays, particularly if they have high copays or deductibles. The moves come after the Inflation Reduction Act, signed into law in 2022, capped out-of-pocket insulin costs for seniors on Medicare at $35 per month.